Как мы стареем

25 Wood, J. G., et al. 2004. “Sirtuin Activators Mimic Caloric Restriction and Delay Ageing in Metazoans”. Nature 430:686–89, https://doi.org/10.1038/nature02789; Valenzano, D. R., et al. 2006. “Resveratrol Prolongs Lifespan and Retards the Onset of Age-Related Markers in a Short-Lived Vertebrate”. Current Biology 16:296–300, https://doi.org/10.1016/j.cub.2005.12.038; Baur, J. A., et al. 2006. “Resveratrol Improves Health and Survival of Mice on a High-Calorie Diet”. Nature 444:337–42, https://doi.org/10.1038/nature05354; Fischer, N., et al. 2017. “The Resveratrol Derivatives Trans-3,5-dimethoxy-4-fluoro-4’ – hydroxystilbene and Trans-2,4’,5-trihydroxystilbene Decrease Oxidative Stress and Prolong Lifespan in Caenorhabditis elegans”. Journal of Pharmacy and Pharmacology 69:73–81, https://doi.org/10.1111/jphp.12657.

26 Hubbard, B. P., et al. 2013. “Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators”. Science 339:1216–19, https://doi.org/10.1126/science.1231097.

27 Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., Partridge, L. 2007. “Effects of Resveratrol on Lifespan in Drosophila melanogaster and Caenorhabditis elegans”. Mechanisms of Ageing and Development 128:546–52, https://doi.org/10.1016/j.mad.2007.07.007; Burnett, C., et al. 2011. “Absence of Effects of Sir2 Overexpression on Lifespan in C. elegans and Drosophila”. Nature 477:482–85, https://doi.org/10.1038/nature10296.

28 Bieganowski, P., Bre

29 Timmerman, L. 2013. “GlaxoSmithKline Shuts Down Sirtris, Five Years after $ 720M Buyout”. Xconomy, March 12, 2013, https://xconomy.com/boston/2013/03/12/glaxosmithkline-shuts-down-sirtris-five-years-after-720m-buyout/.

30 Extra Credits, 2018. “Pellagra – a Medical Mystery – Extra History”. YouTube, July 26, 2018, https://www.youtube.com/watch?v =reYKBgdrZsM.

31 Taber, S. (@SarahTaber_bww), 2021. “The pellagra epidemic came down to the basic fabric of society”. Twitter, July 10, 2021, 2:28 a.m., https://twitter.com/SarahTaber_ bww/status/1413671334853423107.

32 Imai, S., Armstrong, C. M., Kaeberlein, M., Guarente, L. 2000. “Transcriptional Silencing and Longevity Protein Sir2 is an NAD – Dependent Histone Deacetylase”. Nature 403:795–800, https://doi.org/10.1038/ 35001622.

33 Palmer, R. D., Elnashar, M. M., Vaccarezza, M. 2021. “Precursor Comparisons for the Upregulation of Nicotinamide Adenine Dinucleotide: Novel Approaches for Better Aging”. Aging Medicine 4:214–20, https://doi.org/10.1002/agm2.12170; Life Biosciences, n.d., “Jumpstart Fertility – Reversing Reproductive Decline”. Lifespan.io: Crowdsourcing the Cure for Aging, accessed December 21, 2022, https://www.lifespan.io/road-maps/the-rejuvenation-roadmap/jumpstart-fertility-dna-repair.

34 Horowitz, A. M., et al. 2020. “Blood Factors Transfer Beneficial Effects of Exercise on Neurogenesis and Cognition to the Aged Brain”. Science 369:167–73, https://doi.org/10.1126/science.aaw2622.

35 Coppé, J. P., Desprez, P. Y., Krtolica, A., Campisi, J. 2010. “The Senescence- Associated Secretory Phenotype: The Dark Side of Tumor Suppression”. A

36 Kim, E.-C., Kim, J.-R. 2019. “Senotherapeutics: Emerging Strategy for Healthy Aging and Age-Related Disease”. BMB Reports 52:47–55, https://doi.org/10.5483/BMBRep.2019.52.1.293.

37 Atzmon, G., et al. 2010. “Genetic Variation in Human Telomerase Is Associated with Telomere Length in Ashkenazi Centenarians”. Proceedings of the National Academy of Sciences of the USA 107:1710–17, https://doi.org/10.1073/pnas.0906191106.

38 Zhang, C., et al. 2018. “KMT2A Promotes Melanoma Cell Growth by Targeting hTERT Signaling Pathway”. Cell Death and Disease 8: e2940, https://doi.org/10.1038/cddis.2017.285; Reyes-Uribe, P., et al. 2018. “Exploiting TERT De pendency as a Therapeutic Strategy for NRAS-Mutant Melanoma”. Oncogene 37:4058–72, https://doi.org/10.1038/s41388-018-0247-7.

39 Swain, F. 2019. “Buyer Beware of This $ 1 Million Gene Therapy for Aging”. MIT Technology Review, December 6, 2019, https://www.technologyreview.com/2019/12/06/131657/buyer-beware-of-this-1-million-gene-therapy-for-aging/; Mullin, E. 2019. “Scientists Dodge FDA to Offer a $ 1 Million Anti-aging Treatment in Colombia”. OneZero, December 5, 2019, https://onezero.medium.com/scientists-dodge-fda-to-offer-a-1-million-anti-aging-treatment-in-colombia-38756dfb3ad1.

40 Lewis, R. 2019. “Gene Therapy Update: Remembering Jesse Gelsinger”. DNA Science (blog), September 26, 2019, https://dnascience.plos.org/2019/09/26/gene-therapy-update-remembering-jesse-gelsinger/.

41 Journal of Clinical Investigation. 2008. “Why Gene Therapy Caused Leukemia in Some ‘Boy in the Bubble Syndrome’ Patients”. ScienceDaily, August 10, 2008, https://www.sciencedaily.com/releases/2008/08/080807175438.htm.

42 Нaционaльнaя медицинскaя библиотекa США, 2022. “Gene Therapy for APOE4 Homozygote of Alzheimer’s Disease”. ClinicalTrials.gov, id: NCT03634007, последнее обновление 2 декaбря 2022, https://clinicaltrials.gov/ct2/show/NCT03634007.

43 Нaционaльнaя медицинскaя библиотекa США, 2022. “Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects with Idiopathic Parkinson’s Disease”. ClinicalTrials.gov, id: NCT00400634, последнее обновление 10 ноября 2022 г., https://clinicaltrials.gov/ct2/show/NCT00400634.

44 Jiang, T., et al. 2020. “Chemical Modifications of Adenine Base Editor mRNA and Guide RNA Expand Its Application Scope”. Nature Communications 11:1979, https://doi.org/10.1038/s41467-020-15892-8.

45 Koblan, L. W., et al. 2021. “In Vivo Base Editing Rescues Hutchinson-Gilford Progeria Syndrome in Mice”. Nature 589:608–14, https://doi.org/10.1038/s41586-020-03086-7.

46 Kim, J., et al. 2019. “Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease”. New England Journal of Medicine 381:1644–52, https://doi.org/10.1056/NEJMoa1813279.

47 Lu, Y., et al. 2020. “Reprogramming to Recover Youthful Epigenetic Information and Restore Vision”. Nature 588:124–29, https://doi.org/10.1038/s41586-020-2975-4.

48 Barardo, D., et al. 2017. “The DrugAge Database of Aging-Related Drugs”. Aging Cell 16:594–97, https://doi.org/10.1111/acel.12585; “DrugAge: The Database of Ageing-Related Drugs”, бaзa дaнных о геноме человекa при стaрении, genomics.senescence.info/drugs/.

49 Miller, R. A., et al. 2007. “An Aging Interventions Testing Program: Study Design and Interim Report”. Aging Cell 6:565–75, https://doi.org/10.1111/j.1474–9726.2007.00311.x; Banse, S. A., et al. 2019. “Automated Lifespan Determination across Caenorhabditis Strains and Species Reveals Assay-Specific Effects of Chemical Interventions”. Geroscience 41:945–60, https://doi.org/10.1007/s11357-019-00108-9.

50 Strong, R., et al. 2016. “Longer Lifespan in Male Mice Treated with a Weakly Estrogenic Agonist, an Antioxidant, an α-Glucosidase Inhibitor or a Nrf2-Inducer”. Aging Cell 15:872–84, https://doi.org/10.1111/acel.12496.

51 Janssens, G. E., Houtkooper, R. H. 2020. “Identification of Longevity Compounds with Minimized Probabilities of Side Effects”. Biogerontology 21:709–19, https://doi.org/10.1007/s10522-020-09887-7; Wang, Z., Clark, N. R., Ma’ayan, A. 2016. “Drug Induced Adverse Events Prediction with the LINCS L1000 Data Bioinformatics”. https://doi.org/10.1093/bioinformatics/btw168, https://maayanlab.net/SEP-L1000/; Wang, Z., et al. 2016. “Extraction and Analysis of Signatures from the Gene Expression Omnibus by the Crowd”. Nature Communications 7:12846, https://doi.org/10.1038/ncomms12846.

52 Bioage, n.d., “We Are Mapping Human Aging to Develop a Pipeline of Therapies that Treat Disease and Extend Healthy Lifespan”. версия от 21 декaбря 2022, https://bioagelabs.com/?fbclid=IwA R32Tjgt2bgJ-uphqvNtPPjd-7QmQ-tzn0sJctTttNphuFTzuQ0gkd9bONM#pipeline.

53 Reynolds, J. C., et al. 2021. “MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis”. Nature Communications 12:470, https://doi.org/10.1038/s41467-020-20790-0.

54 Bobrov, E., et al. 2018. “PhotoAgeClock: Deep Learning Algorithms for Development of Non-invasive Visual Biomarkers of Aging”. Aging (Albany NY) 10:3249–59, https://doi.org/10.18632/aging.101629; Chen, W., et al. 2015. “Three-Dimensional Human Facial Morphologies as Robust Aging Markers”. Cell Research 25:574–87, https://doi.org/10.1038/cr.2015.36; Xia, X., et al. 2020. “Three-Dimensional Facial-Image Analysis to Predict Heterogeneity of the Human Ageing Rate and the Impact of Lifestyle”. Nature Metabolism 2:946–57, https://doi.org/10.1038/s42255-020-00270-x.

55 Bobrov et al. 2018.

56 Buhr, S. 2017. “A New Lawsuit Alleges Anti-aging Startup Elysium Health Hasn’t Paid Its Sole Supplier”. TechCrunch, January 6, 2017, https://techcrunch.com/2017/01/16/a-new-lawsuit-alleges-anti-aging-startup-elysium-health-hasnt-paid-its-supplier-and-is-in-breach-of-agreement/.

57 Wilfond, B. S., Porter, K. M., Creevy, K. E., Kaeberlein, M., Promislow, D. 2018. “Research to Promote Longevity and Health Span in Companion Dogs: A Pediatric Perspective”. American Journal of Bioethics 18:64–65, https://doi.org/10.1080/15265161.2018.1513591.

58 Kulkarni, A. S., et al. 2018. “Metformin Regulates Metabolic and Nonmetabolic Pathways in Skeletal Muscle and Subcutaneous Adipose Tissues of Older Adults”. Aging Cell 17: e12723, https://doi.org/10.1111/acel.12723.

59 Lee, C. G., et al. 2021. “Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study”. Diabetes Care 44:2775–82, https://doi.org/10.2337/dc21–1046.

60 Konopka, A. R., et al. 2018. “Metformin Inhibits Mitochondrial Adaptations to Aerobic Exercise Training in Older Adults”. Aging Cell 18: e12880, https://doi.org/10.1111/acel.12880; Cai, T., et al. 2021. “Effect of Metformin on Testosterone Levels in Male Patients with Type 2 Diabetes Mellitus Treated with Insulin”. Frontiers in Endocrinology 12:813067, https://doi.org/10.3389/fendo.2021.813067.

61 Wilfond et al. 2018; Kaeberlein, M., Creevy, K. E., Promislow, D. E. 2016. “The Dog Aging Project: Translational Geroscience in Companion Animals”. Mammalian Genome 27:279–88, https://doi.org/10.1007/s00335-016-9638-7.

62 Cotman, C. W., Head, E. 2008. “The Canine (Dog) Model of Human Aging and Disease: Dietary, Environmental and Immunotherapy Approaches”. Journal of Alzheimer’s Disease 15:685–707, https://doi.org/10.3233/jad-2008-15413; Dewey, C. W., Davies, E. S., Xie, H., Wakshlag, J. J. 2019. “Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment”. Veterinary Clinics of North America: Small Animal Practice 49:477–99, https://doi.org/10.1016/j.cvsm.2019.01.013.